Skip to main content
. 2022 Dec 10;20(11):893–914. doi: 10.18502/ijrm.v20i11.12357

Table 4.

Characteristics of studies included in the meta-analysis


Author, yr (Ref) Country Study design PCOS diagnostic criteria Cancer diagnostic criteria PCOS group characteristics Control group characteristics Outcome of interest Adjustments Unadjusted OR (95% CI) Quality assessment
Ding et al. , 2018 (11) Taiwan Cohort ICD-9-CM1 Code 256.4 ICD-9-CM Code 174 and 175 N = 8155 Age = 27.7 (7.0) BMI = Not reported N = 32620 Age = 27.5 (7.9) BMI = Not reported Endometrial, ovarian, and breast cancer Age, comorbidities Endometrial cancer OR: 14.685 (4.096, 52.650) ovarian cancer OR:1.60 (0.62, 4.13) breast cancer OR:0.80 (0.47, 1.35) High
Harris et al. , 2017 (27) US Case-control Not reported Not reported N = 78 Age and BMI not reported for case N = 4063 Age and BMI not reported for control Ovarian cancer Age, study, parity, oral contraceptive use, center, tubal ligation, family history of ovarian cancer 1.16 (0.74, 1.82) High
Kim et al. , 2016 (16) US Case-control Rotterdam criteria Not reported N = 67 Age = 53.8 ± 12.2 BMI = 27.4 ± 6.2 N = 2951 Age = 58.0 ± 12.8 BMI = 26.5 ± 5.7 Breast cancer Age, physical activity 1.30 (0.80, 2.12) High
Shen et al. , 2015 (15) Taiwan Cohort NIH4 or ICD-9-CM ICD-9-CM Code 174 N = 3566 Age = 27.04 (22.66-32.10) BMI = Not reported N = 14264 Age = 27.05 (22.72-32.10) BMI = Not reported Endometrial, ovarian, and breast cancer Age, hypertension, diabetes mellitus, dyslipidemia, coronary artery disease, congestive heart disease, cerebrovascular disease, chronic pulmonary disease, urbanization, and income Endometrial cancer OR: 10.013 (1.942, 51.629) ovarian cancer OR: 0.89 (0.19, 4.12) breast cancer OR: 1.87 (0.99, 3.53) High
Ghasemi et al. , 2012 (29) Iran Case-control Rotterdam Histologically confirmed N = 27 Age = 30-51 BMI not reported N = 305 Age = 30-51 BMI not reported Breast cancer None 0.67 (0.30, 1.48) Moderate
Bodmer et al. , 2011 (33) UK Case-control Used diagnosis from GPRD Based on evidence of cancer-related therapy N = 28 Age = 61.2 ± 13.1 N = 10753 Age = 61.2 ± 13.1 Ovarian cancer BMI, smoking, prior, use of hormones, history o hysterectomy, endometriosis 1.55 (0.63, 3.84) Moderate
Fearnley et al. , 2010 (28) Australia Case-control Not reported Histologically confirmed N = 32 Age < 50 yr BMI = not reported N = 522 Age < 50 yr BMI = Not reported Endometrial cancer BMI 3.638 (1.761, 7.515) High
Zuchetto et al. , 2009 (34) Italy Case-control Not reported Histologically confirmed N = 68 Age = 18-79 BMI not reported N = 1287 Age = 18-79 BMI not reported Endometrial cancer Period of interview, BMI, age at menarche, age at menopause, parity, and oral contraceptive use 1.171 (0.706, 1.943) High
Olsen et al. , 2008 (30) Australia Case-control Not reported Histologically confirmed N = 52 Age = 18-79 BMI not reported N = 3047 Age = 18-79 BMI not reported Ovarian cancer Age, education, parity, hormonal contraceptive use, and BMI 1.15 (0.66, 1.99) High
Wild et al. , 2000 (26) UK Cohort Laparoscopic ICD-7 and ICD-8 N = 319 Age = 38-98 BMI = 27.1 N = 1060 Age = 38-98 BMI = 26.2 Endometrial and breast cancer BMI Endometrial cancer OR: 5.923 (1.721, 20.365) breast cancer OR: 1.21 (0.63, 2.31) High
Anderson et al. , 1997 (17) USA Cohort Not reported ICD codes 174.0-174.9 N = 472 Age = 55-69 BMI = 27.2 ± 0.23 N = 34363 Age = 55-69 BMI = 27 ± 0.03 Breast cancer Age, age at menarche, age at first pregnancy, parity, oral contraceptive use, hormone replacement therapy, BMI, waist to hip ratio, benign breast disease, and family history of breast cancer 1.18 (0.69, 2.01) Moderate
Talamini et al. , 1997 (32) Italy Case-control Not reported Histologically confirmed N = 30 Age = 20-74 BMI not reported N = 5127 Age = 20-74 BMI not reported Breast cancer Age at menarche 0.88 (0.43, 1.81) Moderate
Schildkraut et al. , 1996 (13) USA Case-control Not reported Histologically confirmed N = 31 Age = 20-54 BMI not reported N = 4526 Age = 20-54 BMI not reported Ovarian cancer Age, parity, and oral contraceptive use 2.52 (1.08, 5.89) High
Escobedo et al. , 1991 (31) Georgia Case-control Not reported Histologically confirmed N = 30 Age = 20-54 BMI not reported N = 3593 Age = 20-54 BMI not reported Endometrial cancer Age 3.757 (1.747, 8.081) Moderate
PCOS: Polycystic ovary syndrome, BMI: Body mass index, N: Number, OR: Odds ratio, ICD: International classification of disease, NIH: National institute of health, ICD-9-CM: International classification of diseases, ninth revision, clinical modification, GPRD: General practice research database